Distinguished in Hypercalcemia

Sophie Leboulleux

Gustave Roussy
Villejuif, FR 
Distinguished in Hypercalcemia
Gustave Roussy
Villejuif, FR 
OverviewLocationsClinical Research

Overview

Sophie Leboulleux practices in Villejuif, France. Ms. Leboulleux is rated as a Distinguished expert by MediFind in the treatment of Hypercalcemia. Her top areas of expertise are Thyroid Cancer, Medullary Thyroid Carcinoma, Adrenal Cancer, Thyroidectomy, and Liver Embolization.

Her clinical research consists of co-authoring 201 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Hypercalcemia.

Gender
Female

Locations

Gustave Roussy
Villejuif, 94805, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients With Progressive, Advanced, Kinase Inhibitor Naïve, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)
A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients With Progressive, Advanced, Kinase Inhibitor Naïve, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Selpercatinib, Cabozantinib, Vandetanib
Study Phase: Phase 3
Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?
Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?
Enrollment Status: Active_not_recruiting
Publish Date: May 17, 2023
Intervention Type: Other, Drug
Study Drugs: rhTSH stimulation, I131
Study Phase: Phase 3
First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL)
First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL)
Enrollment Status: Completed
Publish Date: August 04, 2022
Intervention Type: Drug
Study Drug: Sunitinib
Study Phase: Phase 2
A Randomized, Multicenter, Open-label, Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
A Randomized, Multicenter, Open-label, Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
Enrollment Status: Completed
Publish Date: August 16, 2019
Intervention Type: Drug
Study Phase: Phase 2
Single Arm Phase II Trial Evaluating the Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer
Single Arm Phase II Trial Evaluating the Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer
Enrollment Status: Completed
Publish Date: June 11, 2019
Intervention Type: Radiation
Study Phase: Phase 2
Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer
Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer
Enrollment Status: Completed
Publish Date: November 02, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

201 Total Publications

Management of follicular cell-derived thyroid cancer in 2025
Management of follicular cell-derived thyroid cancer in 2025
Journal: Revue medicale suisse
Published: June 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Leboulleux's expertise for a condition
ConditionClose
View All 26 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile